File: /home/jacom/mail/new/1704489472.M442579P20178.server2.shieldcogroup.com,S=8240,W=8385
Return-Path: <010d018cdb7ca7ec-dfbab8ba-8df3-4d78-9413-154a8d9afc4b-000000@ca-central-1.amazonses.com>
Delivered-To: jacom@server2.shieldcogroup.com
Received: from server2.shieldcogroup.com
by server2.shieldcogroup.com with LMTP
id iKnIGQBymGXSTgAAQUL8tA
(envelope-from <010d018cdb7ca7ec-dfbab8ba-8df3-4d78-9413-154a8d9afc4b-000000@ca-central-1.amazonses.com>)
for <jacom@server2.shieldcogroup.com>; Fri, 05 Jan 2024 14:17:52 -0700
Return-path: <010d018cdb7ca7ec-dfbab8ba-8df3-4d78-9413-154a8d9afc4b-000000@ca-central-1.amazonses.com>
Envelope-to: kathy@jacom.ca
Delivery-date: Fri, 05 Jan 2024 14:17:52 -0700
Received: from d208-56.smtp-out.ca-central-1.amazonses.com ([23.249.208.56]:59553)
by server2.shieldcogroup.com with esmtps (TLS1.2) tls TLS_ECDHE_RSA_WITH_AES_128_CBC_SHA256
(Exim 4.96.2)
(envelope-from <010d018cdb7ca7ec-dfbab8ba-8df3-4d78-9413-154a8d9afc4b-000000@ca-central-1.amazonses.com>)
id 1rLrZf-0005FE-0H
for kathy@jacom.ca;
Fri, 05 Jan 2024 14:17:52 -0700
DKIM-Signature: v=1; a=rsa-sha256; q=dns/txt; c=relaxed/simple;
s=mschqtftx2limgdkansknlcfe76mf75b; d=ontario.ca; t=1704489429;
h=From:To:Subject:MIME-Version:Content-Type:Message-ID:Date;
bh=rHDEgXT6Aj47aUzZ02hcLUTBroMuwKLGLTyan+MA90I=;
b=OQaDY7hDfywikG5qjfehFzIgS7nVVaF4z9cnmnICpv4jSMp5E30to2K0QKf54WGd
sozc1E9cKt6UBK3uvCIZ/eKaLVdD+5lA4Ge3/0wUIWNXtf66m6NPor5BLyGRoehygd3
Lz0eSHrbyiAvkDfc0iy+RPZaMuLxv2jeWfc1FVUA=
DKIM-Signature: v=1; a=rsa-sha256; q=dns/txt; c=relaxed/simple;
s=qpcfy54xse57bzmyicqs5kisv46vyagl; d=amazonses.com; t=1704489429;
h=From:To:Subject:MIME-Version:Content-Type:Message-ID:Date:Feedback-ID;
bh=rHDEgXT6Aj47aUzZ02hcLUTBroMuwKLGLTyan+MA90I=;
b=ZiVQ2sOIUzXnkAkSn6CE0Alt1vu/d3H+n6xnOGM8+WhUWRanCu8Mq3wN8boaO460
5ZIlhR2c1jIqHD4A72kWrfy4agS4//ytJsRYzjS80qUFL/23k7Y2I80vFaUfpZ9rMA3
YSwHLrLx13MI/ONNnbY98PGJBMzirbbBGCW1FuS0=
From: Please do not reply to this email as this mail box is not monitored <covaxon@ontario.ca>
To: kathy@jacom.ca
Subject: =?UTF-8?Q?Canadian_Immunization_Research_Network_(CIRN):_Reques?=
=?UTF-8?Q?t_to_Participate_in_Surveillance_for_Adverse_Events_Af?=
=?UTF-8?Q?ter_Immunization_/_Demande_de_participation_=C3=A0_la_surv?=
=?UTF-8?Q?eillance_des_effets_secondaires_suivant_l=E2=80=99immunisation?=
MIME-Version: 1.0
Content-Type: multipart/alternative;
boundary="----=_Part_79592_727531877.1704489428972"
Message-ID: <010d018cdb7ca7ec-dfbab8ba-8df3-4d78-9413-154a8d9afc4b-000000@ca-central-1.amazonses.com>
Date: Fri, 5 Jan 2024 21:17:08 +0000
Feedback-ID: 1.ca-central-1.dAOqdcrWxrZ77cSn3UEwfmw8/7j7I2pJP1pWe1uHY8w=:AmazonSES
X-SES-Outgoing: 2024.01.05-23.249.208.56
X-Spam-Status: No, score=1.7
X-Spam-Score: 17
X-Spam-Bar: +
X-Ham-Report: Spam detection software, running on the system "server2.shieldcogroup.com",
has NOT identified this incoming email as spam. The original
message has been attached to this so you can view it or label
similar future email. If you have any questions, see
root\@localhost for details.
Content preview: Do not reply as this mailbox is not monitored. Hello, The
Canadian National Vaccine Safety Network (CANVAS) supports Canadian monitoring
of vaccine safety by contacting individuals who have recently received a
dose of COVID-19 vaccine and inviting them t [...]
Content analysis details: (1.7 points, 5.0 required)
pts rule name description
---- ---------------------- --------------------------------------------------
0.0 URIBL_BLOCKED ADMINISTRATOR NOTICE: The query to URIBL was
blocked. See
http://wiki.apache.org/spamassassin/DnsBlocklists#dnsbl-block
for more information.
[URIs: awstrack.me]
-0.0 SPF_PASS SPF: sender matches SPF record
0.2 HEADER_FROM_DIFFERENT_DOMAINS From and EnvelopeFrom 2nd level
mail domains are different
-0.0 SPF_HELO_PASS SPF: HELO matches SPF record
0.7 HTML_IMAGE_ONLY_28 BODY: HTML: images with 2400-2800 bytes of
words
0.1 HTTPS_HTTP_MISMATCH BODY: No description available.
0.0 HTML_MESSAGE BODY: HTML included in message
0.7 MPART_ALT_DIFF BODY: HTML and text parts are different
0.1 MIME_HTML_MOSTLY BODY: Multipart message mostly text/html MIME
-0.1 DKIM_VALID_AU Message has a valid DKIM or DK signature from
author's domain
0.1 DKIM_SIGNED Message has a DKIM or DK signature, not necessarily
valid
-0.1 DKIM_VALID Message has at least one valid DKIM or DK signature
-0.1 DKIM_VALID_EF Message has a valid DKIM or DK signature from
envelope-from domain
-0.0 T_SCC_BODY_TEXT_LINE No description available.
0.0 T_REMOTE_IMAGE Message contains an external image
X-Spam-Flag: NO
------=_Part_79592_727531877.1704489428972
Content-Type: text/plain; charset=UTF-8
Content-Transfer-Encoding: 7bit
------=_Part_79592_727531877.1704489428972
Content-Type: text/html; charset=UTF-8
Content-Transfer-Encoding: quoted-printable
<html>
<head>
<body>
<p>Do not reply as this mailbox is not monitored.<br><br></p>
<p>Hello,<br><br></p>
<p>The Canadian National Vaccine Safety Network (CANVAS) supports Canadian =
monitoring of vaccine safety by contacting individuals who have recently re=
ceived a dose of COVID-19 vaccine and inviting them to complete an online q=
uestionnaire about their experience following vaccination. You are being in=
vited to take part because you have recently received a COVID-19 vaccine do=
se and have agreed to be contacted about vaccine studies. If you might be i=
nterested in taking part, please visit <a href=3D"https://fbys6hq7.r.ca-cen=
tral-1.awstrack.me/L0/https:%2F%2FCANVAS-COVID.ca/1/010d018cdb7ca7ec-dfbab8=
ba-8df3-4d78-9413-154a8d9afc4b-000000/_KH0vVCSDol7SfLnUejI2Sxe1Ng=3D140"> h=
ttps://CANVAS-COVID.ca</a> for additional information including how to part=
icipate. Note that if you have previously participated in CANVAS and would =
like to continue, CANVAS would be very grateful to have you back. However, =
you will need to sign up again at the CANVAS website. Your participation is=
entirely voluntary.<br><br></p>
<p>Thank you in advance for your participation.</p>
_____________________________________________________________
<p>Ne pas r=C3=A9pondre =C3=A0 ce courriel; cette adresse n=E2=80=99est pas=
surveill=C3=A9e.<br><br></p>
<p>Bonjour,<br><br></p>
<p>Le r=C3=A9seau national canadien de s=C3=A9curit=C3=A9 vaccinale (CANVAS=
) soutient la surveillance de l=E2=80=99innocuit=C3=A9 des vaccins au Canad=
a en contactant les personnes qui ont r=C3=A9cemment re=C3=A7u une dose de =
vaccin COVID-19 et en les invitant =C3=A0 remplir un questionnaire en ligne=
sur leur exp=C3=A9rience apr=C3=A8s la vaccination. Vous =C3=AAtes invit=
=C3=A9(e) =C3=A0 participer parce que vous avez r=C3=A9cemment re=C3=A7u un=
e dose de vaccin COVID-19 et que vous avez accept=C3=A9 d=E2=80=99=C3=AAtre=
contact=C3=A9(e) au sujet d=E2=80=99=C3=A9tudes sur les vaccins. Si vous s=
ouhaitez participer, veuillez consulter le site suivant <a href=3D"https://=
fbys6hq7.r.ca-central-1.awstrack.me/L0/https:%2F%2Fcanvas-covid.ca%2Ffr%2F/=
1/010d018cdb7ca7ec-dfbab8ba-8df3-4d78-9413-154a8d9afc4b-000000/5gD-emiAeR5n=
UOo_toeGTZOSqZc=3D140"> https://canvas-covid.ca/fr/</a> pour obtenir de plu=
s amples renseignements, notamment sur les modalit=C3=A9s de participation.=
Notez que si vous avez d=C3=A9j=C3=A0 particip=C3=A9 =C3=A0 CANVAS et que =
vous souhaitez continuer, CANVAS vous sera tr=C3=A8s reconnaissant de vous =
retrouver. Cependant, vous devrez vous r=C3=A9inscrire sur le site Web CANV=
AS. Votre participation est enti=C3=A8rement volontaire.<br><br></p>
<p>Nous vous remercions d=E2=80=99avance pour votre participation.
</p>
<img alt=3D"" src=3D"https://fbys6hq7.r.ca-central-1.awstrack.me/I0/010d018=
cdb7ca7ec-dfbab8ba-8df3-4d78-9413-154a8d9afc4b-000000/nLcQc2LxGxsXA8TLOLaVe=
g7uzHk=3D140" style=3D"display: none; width: 1px; height: 1px;">
</body>
</head>
</html>
------=_Part_79592_727531877.1704489428972--